The EuroMena Funds has exited two portfolio companies: a pharmaceutical firm in North Africa and a retail holding in Morocco. We know how to get the job done, no matter the obstacles,” said Romen Mathieu, Co-Founder & Managing Partner of The EuroMena Funds. In December 2013, EuroMena II acquired a minority stake in Biopharm, an Algerian pharmaceutical company that is vertically integrated, covering importation, distribution, direct distribution, and production of pharmaceutical products. However, it has also been the ultimate test of The EuroMena Funds’ strength. Retail Holding, one of Africa’s largest diversified retail groups, expanded from 70 to over 250 points of sale with the EuroMena Funds’ support.

Source: The North Africa Journal October 16, 2024 17:02 UTC